irAE info

Published by: Bristol-Myers Squibb

Description

Приложение “irAE info” предназначено для практикующих врачей, применяющих в своей практике ингибиторы иммунных контрольных точек (ниволумаб, ипилимумаб) при злокачественных новообразованиях у взрослых.
“irAE info” содержит справочную информацию об иммуноопосредованных нежелательных явлениях, свойственных этим препаратам.
Дизайн приложения может упростить и ускорить доступ врача к данной информации.
Hide Show More...

Screenshots

irAE info FAQ

  • Is irAE info free?

    Yes, irAE info is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is irAE info legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does irAE info cost?

    irAE info is free.

  • What is irAE info revenue?

    To get estimated revenue of irAE info app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating

4.33 out of 5

3 ratings in Russia

5 star
2
4 star
0
3 star
1
2 star
0
1 star
0
Ratings History

irAE info Reviews

App doesn't have any reviews yet

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

irAE info Installs

Last 30 days

irAE info Revenue

Last 30 days

irAE info Revenue and Downloads

Gain valuable insights into irAE info performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Languages
English
Recent release
1.0 (3 years ago )
Released on
Nov 26, 2021 (3 years ago )
Also available in
Russia
Last Updated
3 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.